PTX prescient therapeutics limited

Ann: PTX-100 clinical data presented at leading TCL meeting, page-10

  1. 8,346 Posts.
    lightbulb Created with Sketch. 3672
    In comparing the patient numbers (recruited and evaluable) from the two subsets last year, it appears that the latest Complete Responder was actually a CTCL patient. I assumed that it was a PTCL patient given that the goal was to try and recruit more with PTCL which has been challenging.

    Yet another eradication of cancer in anyone's book is a huge achievement considering we're talking cancer! Here's the abstract from the TCL meeting (for those interested):-


    https://hotcopper.com.au/data/attachments/6890/6890543-dd1a5e0f7b5a483bc1a84ad97b884aab.jpg


    https://hotcopper.com.au/data/attachments/6890/6890549-3212d6ff4104ad4bae925c558f9558fe.jpg

    https://hotcopper.com.au/data/attachments/6890/6890546-cf0aa96c7ff46ebd271f2353f4aa6ce8.jpg
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
4.5¢
Change
0.001(2.27%)
Mkt cap ! $36.23M
Open High Low Value Volume
4.5¢ 4.6¢ 4.5¢ $6.007K 133.4K

Buyers (Bids)

No. Vol. Price($)
3 480817 4.5¢
 

Sellers (Offers)

Price($) Vol. No.
4.6¢ 48908 1
View Market Depth
Last trade - 16.10pm 26/06/2025 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.